SoniaMSengMD

Oncology • Fall River, MA

Physician

Join to view full profile

Dr. Seng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Seng's full profile

Already have an account?

Office
363 Highland Ave
Fall River, MA 02720
Phone+1 508-973-7636

Fax+1 508-973-7651
Is this information wrong?

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2008 - 2011
Icahn School of Medicine at Mount SinaiResidency, Internal Medicine/Pediatrics, 2004 - 2008
Albany Medical CollegeClass of 2004

Certifications & Licensure

MA State Medical License 2011 - 2024
NY State Medical License 2006 - 2012
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014

Publications & Presentations

PubMed

Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
Bobby C Liaw, Che-Kai Tsao, Sonia Seng, Tomi Jun, Yixuan Gong, Matthew D Galsky, William K Oh> ;The Oncologist. 2023 Apr 6
28 citations
Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Tracy Proverbs-Singh, Sophia Chiu, Ziyue Liu, Sonia Seng, Guru Sonpavde, Toni K. Choueiri, Che-Kai Tsao, Menggang Yu, Noah M. Hahn, William Oh, Matthew D. Galsky> ;Journal of the National Cancer Institute. 2012 Dec 5
164 citations
Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
Sonia Seng, Ziyue Liu, Sophia Chiu, Tracy Proverbs-Singh, Guru Sonpavde, Toni K. Choueiri, Che-Kai Tsao, Menggang Yu, Noah M. Hahn, William Oh, Matthew D. Galsky> ;Journal of Clinical Oncology. 2012 Nov 13
29 citations
Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer.
Che-Kai Tsao, Erin Moshier, Sonia M. Seng, James Godbold, Steven Grossman, Jonathan A. Winston, William Oh, Matthew D. Galsky> ;Clinical Genitourinary Cancer. 2012 Mar 1
3 citations
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.
Matthew D. Galsky, Sonia Seng, Luis H. Camacho, Elena G. Chiorean, Daniel Mulkerin, David S. Hong, William Oh, Dean F. Bajorin> ;Clinical Genitourinary Cancer. 2011 Sep 1
7 citations
Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
Che-Kai Tsao, Sonia Seng, William Oh, Matthew D. Galsky> ;Clinical Medicine Insights. Oncology. 2011 May 24
Predicting response to platinum chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) using a genomic signature for "BRCAness": A phase II clinical t...
Seng SM, Galsky MD, Tsao C, Li J, Febbo PG, Oh WK> ;J. Clin. Oncol.. 2011-05-20
Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal function on eligibility for cisplatin-based chemotherapy in pat...
Tsao C, Seng SM, Grossman S, Oh WK, Galsky MD> ;J. Clin. Oncol.. 2011-05-20
Join now to see all

Press Mentions

Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: The Non-Androgen-Targetable Pathways in Castration-Resistant Prostate CancerMarch 13th, 2020